Search This Blog

Thursday, July 30, 2020

Alexion Pharmaceuticals EPS beats by $0.53, beats on revenue

Alexion Pharmaceuticals (NASDAQ:ALXN): Q2 Non-GAAP EPS of $3.11 beats by $0.53; GAAP EPS of -$4.84 misses by $6.97.
Revenue of $1.44B (+20.0% Y/Y) beats by $170M.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)